| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Revenue | $1.4M | +50.7% |
| Cost of Revenue | $918K | +57.6% |
| Gross Profit | $554K | +75.3% |
| R&D Expense | $411K | — |
| SG&A Expense | $4.0M | +36.0% |
| Operating Income | -$6.1M | -135.4% |
| Interest Expense | $118K | +1282.5% |
| Pre-tax Income | -$6.2M | -110.6% |
| Net Income | -$6.2M |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.9M | +3118.5% |
| Accounts Receivable | $71K | -34.7% |
| Inventory | $132K | +149.1% |
| Current Assets | $5.5M | +1639.5% |
| Total Assets | $12.7M | +28.3% |
| Current Liabilities | $779K | -69.7% |
| Total Liabilities | $880K | -68.7% |
| Line Item | 2022-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | -845.7% |
| Capital Expenditures | $82K | — |
| Investing Cash Flow | -$82K | -221.8% |
| Financing Cash Flow | $7.6M | +1952.0% |
| Free Cash Flow | -$2.9M | — |
| -110.6% |
| EPS (Basic) | -$0.94 | -84.3% |
| Stockholders' Equity |
| $11.9M |
| +66.8% |